enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Cariprazine - Wikipedia

    en.wikipedia.org/wiki/Cariprazine

    Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, [8] ... At the highest dose ...

  3. List of psychotropic medications - Wikipedia

    en.wikipedia.org/wiki/List_of_psychotropic...

    Vraylar (cariprazine) – atypical antipsychotic used to treat schizophrenia and bipolar mania; W. Wellbutrin IR, SR or XL – an antidepressant of the ...

  4. List of antipsychotics - Wikipedia

    en.wikipedia.org/wiki/List_of_antipsychotics

    Antipsychotics by class Generic name Brand names Chemical class ATC code Typical antipsychotics; Acepromazine: Atravet, Acezine: phenothiazine: N05AA04

  5. Bristol Myers wins US FDA approval for new type of ...

    www.aol.com/news/us-fda-approves-bristol-myers...

    Currently approved antipsychotic drugs include Vanda Pharmaceuticals' Fanapt, AbbVie's Vraylar and generic drugs such as olanzapine, quetiapine and aripiprazole, among others.

  6. High-dose ADHD drugs linked to 81% higher psychosis risk ...

    www.aol.com/high-dose-adhd-drugs-linked...

    Psychosis risk increases 81% on high-dose amphetamine For this study, researchers analyzed medical data from adults between the ages of 16 and 35 treated at Mass General Brigham between 2005 and 2019.

  7. Atypical antipsychotic - Wikipedia

    en.wikipedia.org/wiki/Atypical_antipsychotic

    The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), [1] [2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric ...

  8. An experimental drug drove people to lose 23% of their body ...

    www.aol.com/novo-nordisk-next-generation-weight...

    Lilly’s Zepbound, approved in November 2023 as the Indiana-based drug giant’s answer to Novo Nordisk’s Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase ...

  9. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!